WTAP and renal cell adenocarcinoma: According to recent studies, WTAP is significantly overexpressed in RCC cell lines and tissues, and higher WTAP levels lead to a poor prognosis in patients with RCC (Tang et al., 2018; He et al., 2021; Ying et al., 2021).